Related Experiment Video
Updated: Jun 16, 2026

06:24
Minimal Erythema Dose (MED) Testing
Published on: May 28, 2013
Clinical practice guidelines for pseudoxanthoma elasticum (2017): Clinical Practice Guidelines for Pseudoxanthoma
Akira Iwanaga1, Atsushi Utani1, Yuta Koike1
1Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
The Journal of Dermatology
|January 12, 2022
Summary
Pseudoxanthoma elasticum (PXE) is a rare genetic disorder affecting multiple organs. This report presents the English translation of Japanese clinical guidelines to standardize global patient care.
Area of Science:
- Medical Genetics
- Dermatology
- Ophthalmology
- Vascular Medicine
Background:
- Pseudoxanthoma elasticum (PXE) is a rare, inherited systemic disorder affecting elastic tissues.
- PXE impacts skin, eyes (retina), cardiovascular system, and the gastrointestinal tract, necessitating multidisciplinary care.
- Existing clinical guidelines aim to ensure consistent and equitable medical management for PXE patients.
Purpose of the Study:
- To translate and disseminate the Japanese clinical guidelines for Pseudoxanthoma elasticum (PXE) into English.
- To provide a globally accessible reference for the diagnosis and management of PXE.
- To promote standardized, high-quality medical care for PXE patients worldwide.
Main Methods:
- Translation of the Japanese Dermatological Association's 2017 PXE clinical guidelines.
- Review and adaptation of the translated content for an international audience.
- Dissemination of the English version as a global reference.
Main Results:
- The English version of the Japanese PXE clinical guidelines is now available.
- This resource facilitates worldwide access to expert recommendations for PXE management.
- Standardized care protocols can now be more readily implemented across different regions.
Conclusions:
- The availability of translated guidelines is crucial for improving global health equity in rare diseases like PXE.
- This initiative supports the standardization of diagnostic and therapeutic approaches for PXE.
- Healthcare providers globally can utilize these guidelines to enhance patient outcomes.
Related Concept Videos
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

